Pediatric heart allocation and transplantation in Eurotransplant

  • Jacqueline M Smits
  • Josef Thul
  • Michel De Pauw
  • Eva Delmo Walter
  • Agita Strelniece
  • Dave Green
  • Erwin de Vries
  • Axel Rahmel
  • Juergen Bauer
  • Guenther Laufer
  • Roland Hetzer
  • Hermann Reichenspurner
  • Bruno Meiser

Abstract

Pediatric heart allocation in Eurotransplant (ET) has evolved over the past decades to better serve patients and improve utilization. Pediatric heart transplants (HT) account for 6% of the annual transplant volume in ET. Death rates on the pediatric heart transplant waiting list have decreased over the years, from 25% in 1997 to 18% in 2011. Within the first year after listing, 32% of all infants (<12 months), 20% of all children aged 1-10 years, and 15% of all children aged 11-15 years died without having received a heart transplant. Survival after transplantation improved over the years, and in almost a decade, the 1-year survival went from 83% to 89%, and the 3-year rates increased from 81% to 85%. Improved medical management of heart failure patients and the availability of mechanical support for children have significantly improved the prospects for children on the heart transplant waiting list.

Bibliographical data

Original languageEnglish
ISSN0934-0874
DOIs
Publication statusPublished - 09.2014

Comment Deanary

© 2014 Steunstichting ESOT.

PubMed 24853064